Clinical Trial Update: New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2a clinical trial evaluating a new adjuvant vaccine for newly diagnosed glioblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Newly Diagnosed Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING